Corcept Therapeutics, Inc. (CORT)

43.96 +0.06 (+0.14%) USD  |  NASDAQ  |  Apr 16, 16:00
43.98 +0.02 (+0.03%) After-Hours: 20:00
More

Corcept Therapeutics Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade
Integer Holdings Corp. Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade